Affordable Access

deepdyve-link
Publisher Website

The use of 18F-FDG PET/CT to guide management of adrenal histoplasmosis over time.

Authors
  • Parisien-La Salle, S1
  • Morency-Potvin, P2
  • Lord, M3
  • Mercier, F4
  • Dubé, B P5
  • Cohade, C3, 6
  • Bourdeau, I7
  • 1 Division of Endocrinology, Department of Medicine, Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. , (Canada)
  • 2 Division of Infectious Diseases, Department of Medicine, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. , (Canada)
  • 3 Department of Radiology, Radio-oncology and Nuclear Medicine, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. , (Canada)
  • 4 Surgical Oncology Service, Department of Surgery, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. , (Canada)
  • 5 Division of Respirology, Department of Medicine, Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. , (Canada)
  • 6 Department of Radiology and Nuclear Medicine, Hôpital Maisonneuve-Rosemont, Montreal, Canada. , (Canada)
  • 7 Division of Endocrinology, Department of Medicine, Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Canada. [email protected] , (Canada)
Type
Published Article
Journal
European Journal of Nuclear Medicine
Publisher
Springer-Verlag
Publication Date
Apr 01, 2021
Volume
48
Issue
4
Pages
1250–1251
Identifiers
DOI: 10.1007/s00259-020-05016-1
PMID: 32864717
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times